SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-097930
Filing Date
2024-04-16
Accepted
2024-04-16 17:15:58
Documents
9
Period of Report
2024-05-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A d674951dpre14a.htm PRE 14A 537339
2 GRAPHIC g674951g01a01.jpg GRAPHIC 37467
3 GRAPHIC g674951g01t01.jpg GRAPHIC 439360
4 GRAPHIC g674951g01t02.jpg GRAPHIC 257633
5 GRAPHIC g674951g06a06.jpg GRAPHIC 55920
6 GRAPHIC g674951g13j07.jpg GRAPHIC 17377
7 GRAPHIC g674951g51w01.jpg GRAPHIC 53138
8 GRAPHIC g674951g73l41.jpg GRAPHIC 60831
9 GRAPHIC g674951g90t91.jpg GRAPHIC 23079
  Complete submission text file 0001193125-24-097930.txt   1840876
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39659 | Film No.: 24848676
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)